Live Coverage from the GU Cancers ...
Check out our coverage of the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco, CA
Darolutamide Improves Metastasis-Free Survival in CRPC
Median metastasis-free survival was longer with darolutamide than with placebo: 40.4 vs 18.4 months.
Adding Docetaxel to ADT Not Beneficial ...
In a study of men with nonmetastatic high-risk prostate cancer who have rising PSA after primary therapy, investigators found no significant difference in PSA progression-free survival.
Improving Dialysis for Undocumented Immigrants
Many are calling for standard dialysis coverage for undocumented immigrants with end-stage renal disease.
Post-RT Time to PSA Nadir Predictive
Men with unfavorable-risk prostate cancer who had a detectable PSA nadir and a time to PSA nadir less than 12 months had a 5-fold increased risk of dying from their disease.
Dialysis Death Risk Bigger Than Cancers'
Compared with patients on maintenance dialysis, men with prostate cancer and women with breast cancer have better unadjusted 5-year survival probabilities.
Enarodustat Effective for Renal Anemia
The medication showed promise as correction and maintenance therapy in a phase 2b trial of non-dialysis CKD patients with anemia.
Email Precautions Can Prevent Breaches
Staff at medical practices should be taught to recognize suspicious email messages
When Patients Refuse Treatment
Find Jobs
Check out Renal & Urology News' job board
ZERBAXA (ceftolozane and tazobactam)
For complicated UTIs, including pyelonephritis, and intra-abdominal infections.
TRIFERIC® (ferric pyrophosphate citrate) solution
For iron replacement in adults with chronic kidney disease on hemodialysis.
Avycaz™ (ceftazidime-avibactam)
For treatment of complicated intra-abdominal infections and urinary tract infections.
Cartoons
Online Poll
Jan-Feb Digital Issue
CME Spotlight
Evolving Strategies in the Diagnosis and Management of ADPKD
CME|CE
1.50 Credits
Renal and Urology News Articles
- Obesity Linked With Improved Survival in mCRPC
- Radium-223 Use in mCRPC Differs By Race
- Brachytherapy for Favorable-Risk Prostate Cancer Continues to Decline
- Kidney Damage in Younger Adults Tied to NSAID Use
- Abiraterone, Prednisone With Androgen Deprivation Therapy Show Durable Efficacy in Metastatic Castration-Naive Prostate Cancer
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Anemia
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetes
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Hemodialysis
- Hyperkalemia
- Hyperphosphatemia
- Hypertension
- Hyperuricemia
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Transplantation